Instituto Butantan

Instituto Butantan is a Brazilian biologic research center located in Butantã, in the western part of the city of São Paulo, Brazil

Protecting children from dangerous viruses with oral vaccines

Orally administered vaccine can protect millions from hepatitis B. Oral vaccines are both safer and less expensive than injections. Therefore, researchers are continuously pursuing ways to produce an oral vaccine that is sufficiently effective. Now, University of Copenhagen physicists have delivered virologists a “recipe” for improving vaccine drops using methods from the world of nanophysics.

Protecting children from dangerous viruses with oral vaccines

The Latest Bing News on:

Instituto Butantan Research

Accelerating the Development of a Therapeutic Vaccine for Human Chagas Disease
Upon execution of a manufacturing agreement for the production of Phase I clinical trial material, a productive research clone will be provided to the cGMP manufacturer for the generation of ...
China's Sinovac vaccine is 50,38% effective according to leading Brazilian research center
The Instituto Butantan, the São Paulo-based research institute responsible for developing the vaccine and conducting trials in the country, announced last week the vaccine had a 78% overall ...
Stories for January 2021
The Instituto Butantan, the São Paulo-based research institute responsible for developing the vaccine and conducting trials in the country, announced last week the vaccine had a 78% overall ...
Valneva to Host Symposium on COVID-19 and Chikungunya Vaccine Candidates at 31st European Congress of Clinical Microbiology & Infectious Diseases
To make VLA1553 more accessible to Low and Middle Income Countries (LMIC), Valneva and Instituto Butantan in Brazil signed an agreement ... results and completion of research, development and clinical ...
90% of volunteers developed antibodies after receiving promising coronavirus vaccine
Specifically, Sinovac will collaborate with Instituto Butantan in Brazil on the Phase ... the promising vaccine candidates this year before research has concluded. Aside from Sinovac, four other ...

The Latest Google Headlines on:

Instituto Butantan Research

The Latest Bing News on:

Instituto Butantan Discovery

90% of volunteers developed antibodies after receiving promising coronavirus vaccine
The CoronaVac drug will move to Phase 3, with Sinovac working with Brazil’s Instituto Butantan on the new project. The drug is one of five that have reached Phase 3 clinical trials. The novel co ...
Focus on the genome
“The 5,000 samples sequenced so far are a tiny number for an entire year of epidemic,” says Dr. Ester Sabino, coordinator of the Joint Brazil-UK Centre for Arbovirus Discovery ... coordinated by the ...
An agenda for forgotten diseases
Andricopulo is head of technology transfer at the Center for Innovation in Biodiversity and Drug Discovery (CIBFAR), one of the Research, Innovation, and Dissemination Centers (RIDC) funded by FAPESP, ...
Immunology south of the equator in the Americas
The Nobel Prize he shared with George Köhler, resulting from their discovery of monoclonal antibodies ... two in the state of São Paulo (now called the Butantan Institute and Bacteriological ...